Who invested in Biograph 55?
One investor is on record as having backed Biograph 55 — Developing novel cancer immunotherapy, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
cdn.prod.website-files.comBiograph 55 investors
No round dates are on record for Biograph 55. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Biograph 55 are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.